Healthcare -
Biotechnology - NASDAQ - US
$ 4.41
-2.65 %
$ 204 M
Market Cap
-1.55
P/E
Price Target
Average
826.87%
Revenue Forecast
Estimate
66.70%
EBIT
Estimate
5.25%
Net Income
Estimate
--11.44%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
4D Molecular Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for FDMT of $40.9 , with forecasts ranging from
a
low of
$6 to a high of $63 .
FDMT Lowest Price Target
Wall Street Target
6 USD
36.05%
FDMT Average Price Target
Wall Street Target
40.9 USD
826.87%
FDMT Highest Price Target
Wall Street Target
63 USD
1328.57%
REVENUE FORECAST
Revenue Forecast Chart FDMT
EBIT FORECAST
EBIT Forecast Chart FDMT
NET INCOME FORECAST
Net Income Chart FDMT